Tuesday, 18 July 2023

FDA approves RSV monoclonal antibody to protect infants and young children, a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country

FDA approves RSV monoclonal antibody to protect infants and young children, a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country submitted by /u/statnews
[link] [comments]


from Health https://ift.tt/vXBiyzs
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)